Onaitis Matthew
Insider CIK 1362822 · SOMX SVP, General Counsel · TSRX General Counsel · RXDX General Counsel and Secretary · CDTX Gnrl Counsel, CFO & Secretary
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2018-03-29 | 2018-04-02 | 72,000 | — | $0 | 72,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | M Exercise deriv | 2017-09-18 | 2017-09-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award | 2017-09-18 | 2017-09-19 | 15,000 | — | $0 | 15,872 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2017-03-31 | 2017-04-04 | 55,000 | — | $0 | 55,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2016-07-01 | 2016-07-05 | 110,000 | — | $0 | 110,000 | SEC↗ |
| RXDX Ignyta, Inc. | A Award | 2016-01-07 | 2016-01-11 | 26,400 | — | $0 | 46,400 | SEC↗ |
| RXDX Ignyta, Inc. | A Award deriv | 2015-01-08 | 2015-01-09 | 44,160 | — | $0 | 44,160 | SEC↗ |
| RXDX Ignyta, Inc. | A Award | 2015-01-08 | 2015-01-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 100,000 | $5.83 | $583.0K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | A Award deriv | 2013-05-31 | 2013-06-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| SOMX Pernix Sleep, Inc. | D To issuer | 2013-03-06 | 2013-03-08 | 47,098 | — | $0 | 0 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-12-31 | 2013-01-03 | 1,494 | — | $0 | 54,837 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-11-16 | 2012-11-20 | 30,000 | — | $0 | 57,093 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-09-30 | 2012-10-02 | 15,716 | — | $0 | 186,745 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-07-02 | 2012-07-03 | 15,992 | — | $0 | 171,029 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | S Sale | 2012-01-03 | 2012-01-04 | 9,000 | $0.48 | $4.3K | 155,037 | SEC↗ |